Secure your place at the Digiday Media Buying Summit in Nashville, March 2-4
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Pitch deck: Why Amazon believes its premium streaming inventory is worth the money
Amazon is pitching its DSP to make the case.
In Graphic Detail: The state of the marketing agency sector
Revenue figures from Omnicom, Publicis and Havas, and new employment stats, offer a snapshot on a quickly evolving industry.
Future of Marketing Briefing: The mental gymnastics of principal media
Welcome to the psychological CrossFit class of modern marketing. Here’s how marketers are learning to move through it.